Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma

Br J Haematol. 2019 Sep;186(6):e217-e219. doi: 10.1111/bjh.16114. Epub 2019 Jul 31.
No abstract available

Keywords: TPO-RAs; case series; immune thrombocytopenia; lymphoma; lymphoproliferative disorders.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Benzoates / administration & dosage*
  • Female
  • Humans
  • Hydrazines / administration & dosage*
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Neoplasm Proteins / agonists*
  • Purpura, Thrombocytopenic, Idiopathic / blood
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Pyrazoles / administration & dosage*
  • Receptors, Fc / administration & dosage*
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / administration & dosage*
  • Thrombopoietin / administration & dosage*

Substances

  • Benzoates
  • Hydrazines
  • Neoplasm Proteins
  • Pyrazoles
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • MPL protein, human
  • Thrombopoietin
  • romiplostim
  • eltrombopag